Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · ARCHEAN CHEMICAL IND LTD · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
ARCHEAN CHEMICAL IND LTD
NSE: ACI · BSE: 543657
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals

ARCHEAN CHEMICAL IND LTD

StateQ1 FY27 filed
Last close · 27 Oct 2026₹470.00
Market cap₹5.8k cr
TTM P/E · P/B · EV/EBITDA59.6 · 3.00 · 24.7

Produces bromine and industrial salt from Kutch-based operations, sitting among the few large-scale bromine makers globally. Around this core franchise, the company runs Acume Chemicals — a wholly-owned bromine derivatives subsidiary that turned EBITDA positive in Q1 FY27 — plus Idealis Mudchemie, a three-plant oilfield/mud chemicals unit, and a sulphate of potash (SOP) plant in early ramp-up. Forward growth platforms include SiCSem, a semiconductor subsidiary that signed a fiscal support agreement with the Government of India, and an 18.14% stake in UK-based Offgrid Energy Labs, which opened a 10 MWh zinc-bromide battery pilot in Hampshire in July 2026. Bromine long-term contracts have been largely renegotiated upward with effect from FY27. Logistics and freight are the dominant swing factor in costs — Kutch road construction has doubled trucking distance, adding ~₹200-220/ton, and the U.S.-Iran conflict pushed global freight and fuel sharply higher. Capex is heavy at 35.4% of revenue, reflecting the semiconductor, SOP and brine-field expansion build-out, while raw materials are a relatively small 8.1% of revenue. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Bromine, Industrial Salt, Bromine Derivatives, Oilfield/Mud chemicals, Sulphate of Potash (SOP). Capital-intensive specialty chemicals (capex 35.4% of revenue) with multiple growth platforms

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY23–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY23FY24FY25FY26
Revenue1,4411,3301,0411,081
EBITDA (ex other income)634463274239
margin %44.034.826.322.1
Owners' profit383319162105
EPS, as reported (₹)34.6625.9013.138.66
ROE % · ROCE %26.7 · 38.418.7 · 22.78.7 · 10.65.5 · 7.8
Debt / equity (x)0.010.040.100.24
Cash from operations496379176140
Capex(100)(131)(264)(382)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · ARCHEAN CHEMICAL IND LTD · 28 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 8 quarters

₹ croreQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue240242346292233255301327
Profit before tax2366755840331644
Net profit1648544029241230
EPS (₹)1.283.894.333.252.361.921.132.48
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
PIDILITE INDUSTRIES LTD1,47,58155.713.3639.122.428.014.928.6
SRF LTD69,21432.04.9321.413.113.113.425.2
GUJARAT FLUOROCHEM LTD46,55276.05.8837.07.38.713.527.7
NAVIN FLUORINE INT. LTD42,47653.710.6938.316.716.423.037.5
AETHER INDUSTRIES LIMITED20,36786.48.2955.48.911.4—33.8
DEEPAK NITRITE LTD19,57225.03.3320.39.410.212.621.5
ATUL LTD15,85319.92.5212.910.913.310.923.1
AARTI INDUSTRIES LTD15,83329.82.6617.17.04.413.016.2
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)59.623.082 of 9917%
P/B3.02.857 of 9942%
ROCE6.610.168 of 10636%
ROE5.58.164 of 9936%
Debt / Equity0.20.254 of 9946%
EBITDA margin22.315.531 of 9969%
Revenue growth11.924.473 of 9423%
Profit growth(24.4)55.179 of 9214%
Market cap580369722 of 10880%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · ARCHEAN CHEMICAL IND LTD · 28 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
22 Oct 2026 · CRISIL downgrades bank facility rating to A- with stable outlookcredit debtmedium——
22 Oct 2026 · Board meeting to approve September 2026 quarterly resultsresultslow——
15 Oct 2026 · Promoter Chemikas Speciality LLP pledges additional ACI shares for loansownership changeshigh——
15 Oct 2026 · Promoter Chemikas Speciality LLP pledges 30,000 Archean Chemical sharesownership changeslow——
12 Oct 2026 · Compliance certificate for Q2 FY27 dematerialization filed with exchangescomplianceminimal——
24 Sept 2026 · Trading window closure for Q2 and H1 FY26 resultscomplianceminimal——
23 Sept 2026 · Promoter Chemikas LLP pledges 10.87 lakh ACI shares as loan collateralownership changeshigh——
9 Sept 2026 · Promoter Chemikas Speciality LLP creates small pledge on 30,000 sharesownership changeshigh——
5 Sept 2026 · SBI Mutual Fund trims stake in Archean Chemical via market saleownership changesmedium——
7 Aug 2026 · Archean Chemical Q1 FY27 earnings call transcript filedinvestor communicationsmedium——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in